Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Perspective Therapeutics, Inc. Common Stock (NY: CATX )

2.660 UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EDT, Mar 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 2.660
Bid (Size) 2.400 (1)
Ask (Size) 2.790 (15)
Prev. Close 2.660
Today's Range 2.660 - 2.660
52wk Range 2.320 - 19.05
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Perspective Therapeutics Touts Encouraging Updated Data From Gastrointestinal Cancer Trial, Stock Soars
Perspective Therapeutics shares interim results for [212Pb]VMT-α-NET trial, showing promising safety, stable disease cases, and anti-tumor activity. 
Via Benzinga
Here's How Donald Trump Could Shake Up Health Care — And Biotech Stocks
Biotech stocks have slumped 15% since Donald Trump won his second presidency. That's because Trump comes with unknowns. 
Via Investor's Business Daily
Topics Government
Exposures Political

Performance

YTD
-19.64%
-19.64%
1 Month
-17.90%
-17.90%
3 Month
-22.90%
-22.90%
6 Month
-83.00%
-83.00%
1 Year
-76.87%
-76.87%

More News

Read More
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Dow Jumps Over 100 Points; Nvidia Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Earnings Scheduled For November 12, 2024
Via Benzinga
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
Via Benzinga
Why Perspective Therapeutics (CATX) Shares Are Falling
Via Benzinga
S&P 500 Moves Higher; BlackRock Reports Upbeat Results
Via Benzinga
Topics Stocks
Exposures US Equities
Gold Gains 1%; Wells Fargo Shares Gain After Q3 Earnings
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Cancer-Focused Perspective Therapeutics Stock Trades Lower After Drug Study Report
Via Benzinga
Dow Surges 150 Points; JPMorgan Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
CATX Stock Earnings: Perspective Therapeutics Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
3 Outperforming Stocks Surpassing Even Nvidia This Year
Via InvestorPlace
$1.8M Bet On This Health Care Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
Expensify And 2 Other Stocks Under $2 Insiders Are Buying
Via Benzinga
Insider Trading is Good News for These Stocks
Via MarketBeat
CATX Stock Earnings: Perspective Therapeutics Meets EPS for Q1 2024
Via InvestorPlace
Stocks Pause As Traders Reassess Interest Rate Path, Gold Makes New Highs, Bitcoin Rebounds: What's Driving Markets Thursday?
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Expensify And 3 Other Stocks Under $3 Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
Expensify And 2 Other Stocks Under $2 Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
Perspective Therapeutics And 3 Other Stocks Under $2 Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.